Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312778 | SCV000847234 | likely benign | Inborn genetic diseases | 2018-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001079316 | SCV001116253 | likely benign | Neuronal ceroid lipofuscinosis 13 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000968779 | SCV001148333 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CTSF: BS2 |
Athena Diagnostics | RCV001288581 | SCV001475807 | benign | not specified | 2019-12-18 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000968779 | SCV001716096 | uncertain significance | not provided | 2019-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000968779 | SCV001751165 | likely benign | not provided | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000968779 | SCV001808362 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000968779 | SCV001975743 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003980336 | SCV004787265 | likely benign | CTSF-related disorder | 2020-03-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |